【24h】

In This Issue

机译:在这个问题上

获取原文
获取原文并翻译 | 示例
       

摘要

A major hurdle in the therapeutic use of stem cells involves determining the internal and external factors that give them unique properties such as immortality and sustainability. One cluster of genes that might play an intrinsic role, called the Polycomb-group (PcG) genes, encodes a set of multiprotein complexes called PcG complex 1 and 2. Genetic studies suggest a role for PcG complex 1 in many types of stem cells, but the molecular functions of this complex remain unclear. To investigate the function of PcG complex 1, Motoaki Ohtsubo el al. focused on Geminin-a protein recruited to PcG complex 1 and known to suppress DNA replication licensing-in mouse hematopoietic stem cells (HSCs). They found that PcG complex 1 acts as an E3 ubiquitin ligase for Geminin, tagging Geminin to induce its degradation and facilitating turnover of the protein. Because Geminin expression is higher in HSCs, Ohtsubo et al. say that it may be a key support molecule for HSCs, regulating their proliferation, differentiation, and genomic stability. The authors also suggest that regulation of Geminin by PcG complex 1 could provide a potential target for altering stem cell properties for therapeutic use. - M.M.
机译:干细胞在治疗用途上的主要障碍涉及确定赋予其独特特性(如永生性和可持续性)的内部和外部因素。一个可能起内在作用的基因簇称为Polycomb-group(PcG)基因,编码一组称为PcG complex 1和2的多蛋白复合物。遗传研究表明,PcG复合物1在许多类型的干细胞中都有作用,但是这种复合物的分子功能仍然不清楚。为了研究PcG复合物1的功能,Motoaki Ohtsubo等人。专注于Geminin-一种募集到PcG复合体1的蛋白,已知可抑制小鼠造血干细胞(HSC)的DNA复制许可。他们发现PcG复合物1充当Geminin的E3泛素连接酶,标记Geminin以诱导其降解并促进蛋白质的更新。因为Geminin在HSC中的表达较高,所以Ohtsubo等人。他说,它可能是HSC的关键支持分子,调节其增殖,分化和基因组稳定性。作者还建议,PcG复合物1对Geminin的调控可为改变干细胞特性以用于治疗提供潜在的靶标。 -M.M.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号